SIC
STIM icon

SJS Investment Consulting’s Neuronetics STIM Stock Holding History

SJS Investment Consulting’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-17
Closed -$25 – 2977
2026
Q1 		$25 Buy
+17
New +$27 ﹤0.01% 2349

Other funds holding STIM

AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VA
VestGen Advisors Inverness, Illinois $3.43B AUM 37.73% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
DJYG
David J. Yvars Group University Park, Florida $212M AUM 33.06% 1-Year Est. Return
SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return

SJS Investment Consulting's STIM Position: Q2 2026 in Review

SJS Investment Consulting sold out of Neuronetics (STIM) in Q2 2026, closing a stake of 17 shares — an estimated $25 sold.

SJS Investment Consulting first reported a position in STIM in Q1 2026 and held it in 1 quarter. The position peaked at $25 in Q1 2026. 30 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • SJS Investment Consulting reported no remaining Neuronetics position as of Q2 2026 after selling out during the quarter.
  • SJS Investment Consulting sold 17 Neuronetics shares in Q2 2026, an estimated $25.
  • SJS Investment Consulting first reported a position in Neuronetics in Q1 2026 and held it in 1 quarter.
  • SJS Investment Consulting's Neuronetics position peaked at $25 in Q1 2026.
  • 30 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.